Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment.

Autor: King MR; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Anderson NJ; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Deciu M; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Guernsey LS; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Cundiff M; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Hajizadeh S; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Jolivalt CG; Department of Pathology, University of California San Diego, La Jolla, CA, USA.
Jazyk: angličtina
Zdroj: Journal of neuroscience research [J Neurosci Res] 2020 Nov; Vol. 98 (11), pp. 2357-2369. Date of Electronic Publication: 2020 Aug 01.
DOI: 10.1002/jnr.24706
Abstrakt: Epidemiological studies have pointed at diabetes as a risk factor for Alzheimer's disease (AD) and this has been supported by several studies in animal models of both type 1 and type 2 diabetes. However, side-by-side comparison of the two types of diabetes is limited. We investigated the role of insulin deficiency and insulin resistance in the development of memory impairments and the effect of Exendin-4 (Ex4) treatment in a mouse model of AD. Three-4-month-old female wild type (WT) mice and mice overexpressing human tau and amyloid precursor protein (TAPP) were injected with streptozotocin (STZ) or fed a high-fat diet (HFD). A second study was performed in TAPP-STZ mice treated with Ex4, a long-lasting analog of GLP-1. Plasma and brain were collected at study termination for ELISA, Western blot, and immunohistochemistry analysis. Learning and memory deficits were impaired in TAPP transgenic mice compared with WT mice at the end of the study. Deficits were exaggerated by insulin deficiency in TAPP mice but 12 weeks of insulin resistance did not affect memory performances in either WT or TAPP mice. Levels of phosphorylated tau were increased in the brain of WT-STZ and TAPP-STZ mice but not in the brain of WT or TAPP mice on HFD. In the TAPP-STZ mice, treatment with Ex4 initiated after established cognitive deficits ameliorated learning, but not memory, impairments. This was accompanied by the reduction of amyloid β and phosphorylated tau expression. Theses studies support the role of Ex4 in AD, independently from its actions on diabetes.
(© 2020 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: